These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6738836)
41. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837 [TBL] [Abstract][Full Text] [Related]
42. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
43. Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine. Newman MA; Hee SQ; Schoeny R; Lowry L Cancer Res; 1990 Jun; 50(11):3351-66. PubMed ID: 2334930 [TBL] [Abstract][Full Text] [Related]
44. Hepatopathy following irradiation and chemotherapy for Wilms' tumor. Johnson FL; Balis FM Am J Pediatr Hematol Oncol; 1982; 4(2):217-21. PubMed ID: 6287875 [TBL] [Abstract][Full Text] [Related]
45. Nonconvulsive status epilepticus and leucoencephalopathy after high-dose methotrexate. Patterson DM; Aries J; Hyare H; Holder D; Rees J; Lee SM J Clin Oncol; 2011 Jun; 29(16):e459-61. PubMed ID: 21422437 [No Abstract] [Full Text] [Related]
46. Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats. Limmer S; Eberle N; Nerschbach V; Nolte I; Betz D Vet Comp Oncol; 2016 Aug; 14 Suppl 1():21-31. PubMed ID: 24548273 [TBL] [Abstract][Full Text] [Related]
47. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105 [TBL] [Abstract][Full Text] [Related]
48. m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial. Dana BW; Dahlberg S; Miller TP; Hartsock RJ; Balcerzak S; Coltman CA; Carden JO; Hartley K; Fisher RI J Clin Oncol; 1990 Jul; 8(7):1155-62. PubMed ID: 1694233 [TBL] [Abstract][Full Text] [Related]
50. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia]. Kardos M; Grexa E; Kajtár P Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351 [TBL] [Abstract][Full Text] [Related]
51. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood. Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A; Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738 [TBL] [Abstract][Full Text] [Related]
52. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases. Appel IM; Hop WC; Pieters R Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196 [TBL] [Abstract][Full Text] [Related]
53. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital]. Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940 [No Abstract] [Full Text] [Related]
54. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157 [TBL] [Abstract][Full Text] [Related]
55. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399 [TBL] [Abstract][Full Text] [Related]
56. [Experimental study on antineoplastic agents causing hematopoietic diseases]. Miyazaki S; Take H; Nagayama T Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):38-43. PubMed ID: 4112292 [No Abstract] [Full Text] [Related]
57. Learned taste aversions in children receiving chemotherapy. Bernstein IL Science; 1978 Jun; 200(4347):1302-3. PubMed ID: 663613 [TBL] [Abstract][Full Text] [Related]
58. Renal complications of cytotoxic therapy. Healy HG; Clarkson AR Aust N Z J Med; 1983 Oct; 13(5):531-9. PubMed ID: 6228218 [TBL] [Abstract][Full Text] [Related]
59. Selective restoration of immunosuppressive effect of cytotoxic agents by thymopoietin fragments. Dénes L; Szende B; Hajós G; Szporny L; Lapis K Cancer Immunol Immunother; 1990; 32(1):51-4. PubMed ID: 2289199 [TBL] [Abstract][Full Text] [Related]
60. [Electroencephalographic aspects of central complications of treatment with vincristine]. Amand G; Cornu G Rev Electroencephalogr Neurophysiol Clin; 1974; 4(3):479-83. PubMed ID: 4534538 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]